DK1675601T3 - Moderering af virkningen af enterotoksiner - Google Patents

Moderering af virkningen af enterotoksiner

Info

Publication number
DK1675601T3
DK1675601T3 DK04790307T DK04790307T DK1675601T3 DK 1675601 T3 DK1675601 T3 DK 1675601T3 DK 04790307 T DK04790307 T DK 04790307T DK 04790307 T DK04790307 T DK 04790307T DK 1675601 T3 DK1675601 T3 DK 1675601T3
Authority
DK
Denmark
Prior art keywords
enterotoxins
moderation
effect
Prior art date
Application number
DK04790307T
Other languages
English (en)
Other versions
DK1675601T4 (da
Inventor
Irene Corthesy-Theulaz
Gabriela Bergonzelli
Grigorios Fotopoulos
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34354433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1675601(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of DK1675601T3 publication Critical patent/DK1675601T3/da
Application granted granted Critical
Publication of DK1675601T4 publication Critical patent/DK1675601T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DK04790307.5T 2003-10-13 2004-10-12 Moderering af virkningen af enterotoksiner DK1675601T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03023016 2003-10-13
PCT/EP2004/011416 WO2005039606A2 (en) 2003-10-13 2004-10-12 Moderating the effect of endotoxins

Publications (2)

Publication Number Publication Date
DK1675601T3 true DK1675601T3 (da) 2009-11-09
DK1675601T4 DK1675601T4 (da) 2013-05-06

Family

ID=34354433

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04790307.5T DK1675601T4 (da) 2003-10-13 2004-10-12 Moderering af virkningen af enterotoksiner

Country Status (17)

Country Link
US (1) US8216605B2 (da)
EP (1) EP1675601B2 (da)
JP (1) JP4918361B2 (da)
CN (2) CN102319417B (da)
AR (1) AR047763A1 (da)
AT (1) ATE435022T1 (da)
BR (1) BRPI0415385A (da)
CA (1) CA2542448A1 (da)
DE (1) DE602004021831D1 (da)
DK (1) DK1675601T4 (da)
ES (1) ES2328149T5 (da)
IL (1) IL174978A0 (da)
MY (1) MY140220A (da)
PT (1) PT1675601E (da)
TW (1) TW200520696A (da)
WO (1) WO2005039606A2 (da)
ZA (1) ZA200603824B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1689417A2 (en) * 2003-10-13 2006-08-16 Nestec S.A. Moderating the effect of endotoxins
CN113729228A (zh) * 2020-05-29 2021-12-03 安琪纽特股份有限公司 用于预防或改善腹泻的组合物及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US177534A (en) * 1876-05-16 Improvement in meat-extracts
US4595590A (en) * 1984-01-17 1986-06-17 Laboratoires Biocodex Method for preventing or treating pseudo-membranous colitis
JPS61236727A (ja) * 1985-04-12 1986-10-22 Advance Res & Dev Co Ltd 抗う蝕乃至抗菌周症剤
JP2805490B2 (ja) † 1989-02-07 1998-09-30 雪印乳業株式会社 細菌毒素中和剤
CN1056750C (zh) * 1993-12-10 2000-09-27 济南三株药业有限公司 一种营养保健口服液及其制法
US5550106A (en) * 1994-03-04 1996-08-27 Bristol-Myers Squibb Company Low buffer nutritional composition
RU2168915C2 (ru) * 1996-03-19 2001-06-20 Алтайский научно-исследовательский проектно-технологический институт животноводства Мясной продукт для детского питания
US7374753B1 (en) * 1997-06-03 2008-05-20 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
JP2001008636A (ja) * 1999-06-30 2001-01-16 Tanabe Seiyaku Co Ltd 感染症防止用飼料組成物
JP2001055338A (ja) * 1999-08-13 2001-02-27 Kirin Brewery Co Ltd 酵母細胞壁画分からなる薬理用組成物
JP3307627B2 (ja) * 2000-02-09 2002-07-24 オク タイン 酵母ジゴサッカロマイシスロキシイ（Ｚｙｇｏｓａｃｃｈａｒｏｍｙｃｅｓｒｏｕｘｉｉ）からサイトカラシン（Ｃｙｔｏｃｈａｌａｓｉｎ）様物質群を製造する方法。
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
JP2002080351A (ja) 2000-09-07 2002-03-19 Natl Fedelation Of Agricult Coop Assoc 免疫増強剤
SE0003958D0 (sv) * 2000-10-31 2000-10-31 Biogaia Fermentation Ab Method for growth of microorganisms
FI114895B (fi) * 2001-05-14 2005-01-31 Suomen Rehu Oy Ravinnon lisäaine
EP1411952B1 (en) † 2001-06-29 2009-04-22 Glykos Finland Oy Use of at least one glycoinhibitor substance against infectious diseases
NZ537706A (en) * 2002-06-28 2008-03-28 Puleva Biotech Sa Probiotic microbial strains, comprising non-pathogenic strains which are capable of surviving in and being transferred to breast milk and/or amniotic fluid after oral intake in healthy individuals without colonizing other internal organs except mucousas
EP1531832B1 (en) † 2002-06-28 2009-04-15 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
ATE339114T1 (de) * 2002-07-23 2006-10-15 Wrigley W M Jun Co Verkapselte aromastoffe und kaugummi damit
EP1689417A2 (en) † 2003-10-13 2006-08-16 Nestec S.A. Moderating the effect of endotoxins

Also Published As

Publication number Publication date
CN102319417B (zh) 2014-08-13
EP1675601B1 (en) 2009-07-01
ES2328149T3 (es) 2009-11-10
IL174978A0 (en) 2006-08-20
US8216605B2 (en) 2012-07-10
EP1675601B2 (en) 2013-04-10
TW200520696A (en) 2005-07-01
AR047763A1 (es) 2006-02-22
JP2007527410A (ja) 2007-09-27
CN1886144A (zh) 2006-12-27
PT1675601E (pt) 2009-08-31
DE602004021831D1 (de) 2009-08-13
EP1675601A2 (en) 2006-07-05
JP4918361B2 (ja) 2012-04-18
WO2005039606A3 (en) 2005-09-15
ZA200603824B (en) 2007-07-25
MY140220A (en) 2009-12-31
BRPI0415385A (pt) 2006-12-12
CA2542448A1 (en) 2005-05-06
ES2328149T5 (es) 2013-07-12
DK1675601T4 (da) 2013-05-06
US20070122453A1 (en) 2007-05-31
WO2005039606A2 (en) 2005-05-06
ATE435022T1 (de) 2009-07-15
CN102319417A (zh) 2012-01-18

Similar Documents

Publication Publication Date Title
DE602004018654D1 (de) Se
DE50304983D1 (de) Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren
DE60330694D1 (de) Pyrimidopyrimidone als kinaseinhibitoren
DE602004008136D1 (de) Härtbare Zusammensetzung
DE60311148D1 (de) Acrylat- bindemittel
ITMI20041123A1 (it) Fissaggio
AT502792A5 (de) Düsenanpressvorrichtung
DK1492934T3 (da) Dørenhed
DE60331383D1 (de) Dämpfer
ATA662003A (de) Trink-mundstück
DE602004025335D1 (de) Dämpfer
NO20034599D0 (no) Brokonstruksjon
ATE444953T1 (de) Substituierte spirobenzazepine
DE502004009935D1 (de) Substituierte dihydrochinazoline ii
DK1675601T3 (da) Moderering af virkningen af enterotoksiner
DE602004007823D1 (de) Steuer-anordnung
ATA5212002A (de) Teleskop
FR2840006B1 (fr) Construction demontable
FR2855615B1 (fr) Anemometre
ES1054167Y (es) Foco orientable
AT6592U3 (de) Frontgrubber
ATA1802003A (de) Verbundhonring
ATA80232004A (de) Kurbelgehäuse
FI20030321A (fi) Savupelti
FI20020946A0 (fi) Savupelti